EQT Fund Management S.a r.l.
Follow13F filer, CIK 1834239, LUXEMBOURG, Luxembourg
EQT Fund Management S.a r.l. reported $1,020,749,006 across 5 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-224227
- Period
- 2026-03-31
- Reported value
- $1.02B
- Holdings
- 5
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| AGMBnew | +5,141,992 | $53.9M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q1 2026
Share positions as resolved from 13F-HR 0001193125-26-224227, largest first. % of portfolio is the value over $1,020,749,006, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| WAYWAYSTAR HLDG CORP | 24,879,437 | $600M | 58.77% | 0 | Timeline | ||
| OCSOCULIS HOLDING AG | 5,900,294 | $157M | 15.37% | 0 | Timeline | ||
| EVMNEVOMMUNE INC | 4,929,633 | $113M | 11.1% | 0 | Timeline | ||
| PHVSPHARVARIS N V | 3,424,609 | $96.7M | 9.48% | 0 | Timeline | ||
| AGMBAGOMAB THERAPEUTICS NV | 5,141,992 | $53.9M | 5.28% | new | Timeline |
How Q1 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-224227 | base | 2026-05-14 | acceptance time not in the bulk data set |